top
Search terms
Results 1 - 1 of 1 - ordered by :
Ehjournal

The X-VeRT trial randomly compared rivaroxaban (20 or 15 mg/day with renal failure) or dose-adjusted vitamin K antagonists (VKAs) in 1504 patients with atrial fibrillation (AF) undergoing elective ...

European Heart Journal, ISSUE @ A GLANCE, Thomas F. Lüscher

Date : 14/12/2014